NCT03914079

Brief Summary

The primary purpose of this multi-center study is to collect and study the acoustic and electrical signals created by the heart during the cardiac cycle as a result of stenosis or plaque associated with coronary artery disease (CAD).

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

3 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 5, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 16, 2019

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

January 12, 2021

Status Verified

January 1, 2021

Enrollment Period

3.7 years

First QC Date

January 31, 2019

Last Update Submit

January 11, 2021

Conditions

Keywords

Coronary Artery DiseaseCardiovascular DiseaseAtherosclerosisCoronary OcclusionNon-Invasive Medical DeviceCardiac Diagnostics

Outcome Measures

Primary Outcomes (1)

  • Number of Participants suspected of having Coronary Artery Disease

    Collection of all acoustic cardiac data to allow for the acoustic discrimination of the presence and degree of CAD in diseased and healthy participants.

    up to 1 Year

Secondary Outcomes (2)

  • Estimation of coronary artery stenosis by the CAD-det device.

    up to 1 year

  • Estimation of coronary artery stenosis by CCTA and ICA categorized by sex as:

    up to 1 year

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Up to 2,000 men and women age 19 and over with suspected or known CAD referred for clinically indicated Invasive Coronary Angiography (ICA) or Coronary Computed Tomography Angiography (CCTA).

You may qualify if:

  • Age ≥ 19 years;
  • Suspected or known CAD;
  • Able and willing to comply with the study procedures;
  • Referred to ICA or CCTA for CAD characterization;
  • Willingness and ability to sign the Informed Consent Form.

You may not qualify if:

  • Unwillingness or inability to provide informed consent;
  • Age less than 19 years;
  • Pregnancy;
  • Skin injury/diseases/lesions that would preclude safe application of the CAD-det device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Foothills Medical Centre (University of Calgary)

Calgary, Alberta, T2N 2T9, Canada

Location

Horizon Health Network, Saint John Regional Hospital

Saint John, New Brunswick, E2L 4L5, Canada

Location

University of Ottawa Heart Institute

Ottawa, Ontario, K1Y 4W7, Canada

Location

Related Publications (1)

  • Makaryus AN, Makaryus JN, Figgatt A, Mulholland D, Kushner H, Semmlow JL, Mieres J, Taylor AJ. Utility of an advanced digital electronic stethoscope in the diagnosis of coronary artery disease compared with coronary computed tomographic angiography. Am J Cardiol. 2013 Mar 15;111(6):786-92. doi: 10.1016/j.amjcard.2012.11.039. Epub 2013 Jan 1.

    PMID: 23290309BACKGROUND

Related Links

MeSH Terms

Conditions

Coronary Artery DiseaseCardiovascular DiseasesAtherosclerosisCoronary Occlusion

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Benjamin Chow, MD, FRCP(C)

    University of Ottawa Heart Institute (UOHI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2019

First Posted

April 16, 2019

Study Start

April 5, 2019

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

January 12, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations